These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 7843911

  • 1. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
    Sonoda Y, Sano Y, Ksander B, Streilein JW.
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
    [Abstract] [Full Text] [Related]

  • 2. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y, Ksander BR, Streilein JW.
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [Abstract] [Full Text] [Related]

  • 3. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
    Sano Y, Ksander BR, Streilein JW.
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
    [Abstract] [Full Text] [Related]

  • 4. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J, Kurimoto I, Streilein JW.
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [Abstract] [Full Text] [Related]

  • 5. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y, Ksander BR, Streilein JW.
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [Abstract] [Full Text] [Related]

  • 6. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
    Joo CK, Pepose JS, Stuart PM.
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
    [Abstract] [Full Text] [Related]

  • 7. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice.
    Sano Y, Ksander BR, Streilein JW.
    Transpl Immunol; 1996 Mar; 4(1):53-6. PubMed ID: 8762011
    [Abstract] [Full Text] [Related]

  • 8. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z, Sproule TJ, Roopenian DC, Ksander AB.
    Transplantation; 2003 Apr 27; 75(8):1368-74. PubMed ID: 12717232
    [Abstract] [Full Text] [Related]

  • 9. Impaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts.
    Sonoda Y, Streilein JW.
    J Immunol; 1993 Mar 01; 150(5):1727-34. PubMed ID: 8436812
    [Abstract] [Full Text] [Related]

  • 10. Immune privilege and immunogenicity reside among different layers of the mouse cornea.
    Hori J, Joyce NC, Streilein JW.
    Invest Ophthalmol Vis Sci; 2000 Sep 01; 41(10):3032-42. PubMed ID: 10967061
    [Abstract] [Full Text] [Related]

  • 11. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
    Yamada J, Ksander BR, Streilein JW.
    Invest Ophthalmol Vis Sci; 2001 Feb 01; 42(2):386-92. PubMed ID: 11157871
    [Abstract] [Full Text] [Related]

  • 12. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS, Niederkorn JY.
    J Immunol; 1986 Jun 15; 136(12):4362-71. PubMed ID: 3519767
    [Abstract] [Full Text] [Related]

  • 13. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K, Hori J, Kagaya F, Usui T, Amano S, Oshika T, Mizouchi T, Tsuru T, Yamagami S.
    Exp Eye Res; 2000 Jun 15; 70(6):737-43. PubMed ID: 10843778
    [Abstract] [Full Text] [Related]

  • 14. Detection of minor alloantigen-specific cytotoxic T cells after rejection of murine orthotopic corneal allografts: evidence that graft antigens are recognized exclusively via the "indirect pathway".
    Sano Y, Streilein JW, Ksander BR.
    Transplantation; 1999 Oct 15; 68(7):963-70. PubMed ID: 10532535
    [Abstract] [Full Text] [Related]

  • 15. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J, Streilein JW.
    Invest Ophthalmol Vis Sci; 1997 Dec 15; 38(13):2833-43. PubMed ID: 9418737
    [Abstract] [Full Text] [Related]

  • 16. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
    Sonoda A, Sonoda Y, Muramatu R, Streilein JW, Usui M.
    Invest Ophthalmol Vis Sci; 2000 Mar 15; 41(3):790-8. PubMed ID: 10711695
    [Abstract] [Full Text] [Related]

  • 17. Anterior chamber-associated immune deviation promotes corneal allograft survival.
    Niederkorn JY, Mellon J.
    Invest Ophthalmol Vis Sci; 1996 Dec 15; 37(13):2700-7. PubMed ID: 8977485
    [Abstract] [Full Text] [Related]

  • 18. Corneal allografts induce cytotoxic T cell but not delayed hypersensitivity responses in mice.
    Peeler J, Niederkorn J, Matoba A.
    Invest Ophthalmol Vis Sci; 1985 Nov 15; 26(11):1516-23. PubMed ID: 2414248
    [Abstract] [Full Text] [Related]

  • 19. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.
    Hori J, Streilein JW.
    Invest Ophthalmol Vis Sci; 2001 Mar 15; 42(3):720-6. PubMed ID: 11222533
    [Abstract] [Full Text] [Related]

  • 20. Major histocompatibility complex semi-matching improves murine corneal allograft survival under oxidative macrophage dominancy.
    Yamada J, Hamuro J, Terai K, Kinoshita S.
    Transplantation; 2007 Oct 15; 84(7):899-907. PubMed ID: 17984844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.